Yo-Yo dieting without additional treatment can explain high placebo response rates in NASH clinical trials
“RENAsym, our newest QST platform, will allow us to help companies developing new therapeutics understand and avoid potential kidney injury issues as well, thereby expanding the reach of our software and associated consulting services into an important area.”
The University+ Program offers free one-year access to Simulations Plus software to students and educators at accredited universities worldwide and is renewable provided eligibility conditions are met.
To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.
Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.
Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.
Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticianby bringing breakthrough advances to the modeling & simulation community in user-friendly tools.
Stay up-to-date with our upcoming conference attendance & presentations, application webinars, and training workshop courses.
Find out how your peers are applying our technology by reviewing journal articles describing various user case studies.